Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

T-cell therapy after hematopoietic stem cell transplantation (HSCT) has been used alone or in combination with immunosuppression to cure hematologic malignancies and to prevent disease recurrence. Here, we describe the outcome of patients with high-risk/advanced stage hematologic malignancies, who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacchetta, Rosa, Lucarelli, Barbarella, Sartirana, Claudia, Gregori, Silvia, Lupo Stanghellini, Maria T., Miqueu, Patrick, Tomiuk, Stefan, Hernandez-Fuentes, Maria, Gianolini, Monica E., Greco, Raffaella, Bernardi, Massimo, Zappone, Elisabetta, Rossini, Silvano, Janssen, Uwe, Ambrosi, Alessandro, Salomoni, Monica, Peccatori, Jacopo, Ciceri, Fabio, Roncarolo, Maria-Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907718/
https://www.ncbi.nlm.nih.gov/pubmed/24550909
http://dx.doi.org/10.3389/fimmu.2014.00016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907718/
https://www.ncbi.nlm.nih.gov/pubmed/24550909
http://dx.doi.org/10.3389/fimmu.2014.00016

Ejemplares similares